MLchartDataset catalogue

saxagliptin hydrochloride

Term · Oncology and biomedicine · MLC-T-ONC-016653

The hydrochloride salt form of saxagliptin, an orally bioavailable, potent, selective and competitive, cyanopyrrolidine-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Saxagliptin is metabolized into an, although less potent, active mono-hydroxy metabolite.

Table 1. Record
IdentifierMLC-T-ONC-016653
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-016653",
  "term": "saxagliptin hydrochloride",
  "field": "Oncology and biomedicine",
  "definition": "The hydrochloride salt form of saxagliptin, an orally bioavailable, potent, selective and competitive, cyanopyrrolidine-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Saxagliptin is metabolized into an, although less potent, active mono-hydroxy metabolite.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/saxagliptin-hydrochloride/"
}

Record 14,706 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.